Daan Gene (002030.SZ) Earnings Analysis
Daan Gene (002030.SZ) next reports earnings on 2026-08-29. Trailing P/E -8.14.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 002030.SZ next report earnings?
| Next earnings date | 2026-08-29 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
002030.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-27 | -0.07 CNY | n/a | n/a | n/a |
| 2025-10-30 | 0.02897 CNY | n/a | n/a | n/a |
| 2025-06-30 | -0.17768 CNY | n/a | n/a | n/a |
| 2024-08-30 | -0.0256 CNY | n/a | n/a | n/a |
002030.SZ valuation and analyst view
| Trailing P/E | -8.14 |
|---|---|
| Trailing EPS | -0.6386 CNY |
| Price / book | 1.06 |
| Dividend yield | 0.00% |
| Market cap | 7.31B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Daan Gene (002030.SZ)'s next earnings date?
Daan Gene is next scheduled to report on 2026-08-29.
Did 002030.SZ beat earnings last quarter?
Consensus estimate data was not available for 002030.SZ's 2026-04-27 report.
What is 002030.SZ's current P/E ratio and EPS?
002030.SZ trades at a trailing P/E of -8.14 on trailing EPS of -0.6386040429501684 CNY.
What do analysts rate 002030.SZ?
002030.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.